{"title":"Risk Factors and Epidemiological Trends (1990-2021) in Esophageal Cancer Across East and South Asia.","authors":"Lovely Jain, Vikas Singh, Shalini Singla","doi":"10.1080/07357907.2025.2600079","DOIUrl":null,"url":null,"abstract":"<p><p>Esophageal cancer remains a leading cause of cancer-related morbidity and mortality worldwide, with East and South Asia bearing a disproportionate burden. Despite global declines in age-standardized rates, these regions continue to face challenges due to sociodemographic and behavioral factors. Using Global Burden of Disease 2021 data, we analyzed trends in prevalence, incidence, mortality, and Disability-Adjusted Life Years (DALYs) from 1990 to 2021, emphasizing gender disparities and risk factor contributions. East Asia showed notable progress, with China reporting a 33.96% decrease in age-standardized incidence rate (ASIR) and a 45.78% decline in age-standardized mortality rate (ASMR). Korea also demonstrated improvements, whereas Taiwan recorded only a 4.69% reduction in ASIR but a striking 141.62% rise in ASMR. In South Asia, Bangladesh achieved a 32.74% fall in ASIR and Nepal a 19.01% decline, while Pakistan reported increases in both ASIR (+8.47%) and ASMR (+8.52%). Gender analyses revealed higher ASIR and ASMR among men, except in Pakistan where chewing tobacco drove higher female rates. Tobacco use accounted for 53.1% of the burden in South Asia and 55.2% in East Asia, dominated by smoking in East Asia and chewing tobacco in South Asia. These findings highlight the need for gender-sensitive interventions, stronger tobacco control, dietary improvement, and enhanced screening.</p>","PeriodicalId":9463,"journal":{"name":"Cancer Investigation","volume":" ","pages":"372-385"},"PeriodicalIF":2.2000,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer Investigation","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/07357907.2025.2600079","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/12/18 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Esophageal cancer remains a leading cause of cancer-related morbidity and mortality worldwide, with East and South Asia bearing a disproportionate burden. Despite global declines in age-standardized rates, these regions continue to face challenges due to sociodemographic and behavioral factors. Using Global Burden of Disease 2021 data, we analyzed trends in prevalence, incidence, mortality, and Disability-Adjusted Life Years (DALYs) from 1990 to 2021, emphasizing gender disparities and risk factor contributions. East Asia showed notable progress, with China reporting a 33.96% decrease in age-standardized incidence rate (ASIR) and a 45.78% decline in age-standardized mortality rate (ASMR). Korea also demonstrated improvements, whereas Taiwan recorded only a 4.69% reduction in ASIR but a striking 141.62% rise in ASMR. In South Asia, Bangladesh achieved a 32.74% fall in ASIR and Nepal a 19.01% decline, while Pakistan reported increases in both ASIR (+8.47%) and ASMR (+8.52%). Gender analyses revealed higher ASIR and ASMR among men, except in Pakistan where chewing tobacco drove higher female rates. Tobacco use accounted for 53.1% of the burden in South Asia and 55.2% in East Asia, dominated by smoking in East Asia and chewing tobacco in South Asia. These findings highlight the need for gender-sensitive interventions, stronger tobacco control, dietary improvement, and enhanced screening.
期刊介绍:
Cancer Investigation is one of the most highly regarded and recognized journals in the field of basic and clinical oncology. It is designed to give physicians a comprehensive resource on the current state of progress in the cancer field as well as a broad background of reliable information necessary for effective decision making. In addition to presenting original papers of fundamental significance, it also publishes reviews, essays, specialized presentations of controversies, considerations of new technologies and their applications to specific laboratory problems, discussions of public issues, miniseries on major topics, new and experimental drugs and therapies, and an innovative letters to the editor section. One of the unique features of the journal is its departmentalized editorial sections reporting on more than 30 subject categories covering the broad spectrum of specialized areas that together comprise the field of oncology. Edited by leading physicians and research scientists, these sections make Cancer Investigation the prime resource for clinicians seeking to make sense of the sometimes-overwhelming amount of information available throughout the field. In addition to its peer-reviewed clinical research, the journal also features translational studies that bridge the gap between the laboratory and the clinic.